- Home
- MED vs ELDN Comparison
MED vs ELDN Comparison
Compare MED & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- ELDN
- Stock Information
- Founded
- MED 1980
- ELDN 2004
- Country
- MED United States
- ELDN United States
- Employees
- MED N/A
- ELDN N/A
- Industry
- MED Packaged Foods
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- ELDN Health Care
- Exchange
- MED Nasdaq
- ELDN Nasdaq
- Market Cap
- MED 150.7M
- ELDN 164.1M
- IPO Year
- MED N/A
- ELDN N/A
- Fundamental
- Price
- MED $12.91
- ELDN $3.44
- Analyst Decision
- MED Hold
- ELDN Strong Buy
- Analyst Count
- MED 1
- ELDN 2
- Target Price
- MED $16.50
- ELDN $12.50
- AVG Volume (30 Days)
- MED 136.4K
- ELDN 1.4M
- Earning Date
- MED 11-03-2025
- ELDN 11-11-2025
- Dividend Yield
- MED N/A
- ELDN N/A
- EPS Growth
- MED N/A
- ELDN N/A
- EPS
- MED 0.33
- ELDN 0.21
- Revenue
- MED $480,449,000.00
- ELDN N/A
- Revenue This Year
- MED N/A
- ELDN N/A
- Revenue Next Year
- MED N/A
- ELDN N/A
- P/E Ratio
- MED $39.16
- ELDN $16.22
- Revenue Growth
- MED N/A
- ELDN N/A
- 52 Week Low
- MED $11.57
- ELDN $2.32
- 52 Week High
- MED $21.98
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- MED 38.72
- ELDN 71.04
- Support Level
- MED $12.80
- ELDN $2.58
- Resistance Level
- MED $13.48
- ELDN $2.71
- Average True Range (ATR)
- MED 0.40
- ELDN 0.22
- MACD
- MED -0.10
- ELDN 0.05
- Stochastic Oscillator
- MED 19.26
- ELDN 77.87
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.